MEDU-45. DEVELOPMENT OF A NEW ETOPOSIDE-BOUND MAGNETIC NANOPARTICLE DESIGNED TO TREAT MEDULLOBLASTOMA CELLS DISSEMINATED WITHIN CEREBROSPINAL FLUID PATHWAYS | Zendy

AI Assistant Blog Pricing

MEDU-45. DEVELOPMENT OF A NEW ETOPOSIDE-BOUND MAGNETIC NANOPARTICLE DESIGNED TO TREAT MEDULLOBLASTOMA CELLS DISSEMINATED WITHIN CEREBROSPINAL FLUID PATHWAYS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.